STATE OF WISCONSIN INVESTMENT BOARD
Position in RLAY — Relay Therapeutics, Inc.
CIK 854157
MADISON, WI
Position in RLAY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,356,505
+$742,257 QoQ
Shares Held
125,949
-22.4% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#98
of 256 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE OF WISCONSIN INVESTMENT BOARD holds $511,704,326 across 163 Biotechnology names. RLAY ranks #54 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
135,798 | $67,454,940 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
55,287 | $34,473,655 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
70,171 | $21,123,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
83,892 | $15,711,293 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
248,821 | $15,018,835 | |
| 6 | MRNA |
Moderna, Inc.
|
207,705 | $14,545,581 | |
| 7 | INSM |
INSMED Inc
|
118,057 | $12,587,237 | |
| 8 | RPRX |
Royalty Pharma plc
|
213,373 | $11,963,824 |
All Filings in RLAY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,356,505 | 125,949 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,614,248 | 162,236 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $855,813 | 101,160 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $424,824 | 81,384 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $263,454 | 100,555 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $276,773 | 67,178 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $552,664 | 78,060 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $650,669 | 99,796 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $484,329 | 58,353 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,072,219 | 97,386 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $718,113 | 85,388 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $864,454 | 68,826 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,193,943 | 72,492 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,137,606 | 76,145 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,539,794 | 68,833 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $881,133 | 52,605 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,786,483 | 93,100 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,859,101 | 93,100 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,386,821 | 75,700 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,769,863 | 75,700 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,132,969 | 61,700 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,886,824 | 45,400 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $2,172,090 | 51,000 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||